GlobeNewsWire · KYTX · October 21, 2026

Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto

Get the app for more

Explore stock news, insights and company research.